{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:48:00Z","timestamp":1771955280889,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002635","name":"Inha University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006474","name":"Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bbrc.2020.04.157","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T07:46:24Z","timestamp":1589787984000},"page":"979-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Liver-selective \u03b3-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis"],"prefix":"10.1016","volume":"527","author":[{"given":"KyeongJin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ku","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-5273","authenticated-orcid":false,"given":"John P.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utpal B.","family":"Pajvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.04.157_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pathol.2018.10.013","article-title":"Diet, exercise and weight loss and dyslipidaemia","volume":"51","author":"Clifton","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.bbrc.2020.04.157_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2020.04.157_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib5","doi-asserted-by":"crossref","first-page":"1K","DOI":"10.1016\/j.amjcard.2008.10.002","article-title":"The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia","volume":"102","author":"Fruchart","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.bbrc.2020.04.157_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MOL.0000000000000348","article-title":"Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism","volume":"27","author":"Chan","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tem.2015.02.006","article-title":"Notch signaling as a novel regulator of metabolism","volume":"26","author":"Bi","year":"2015","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib9","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American heart association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ahj.2017.09.004","article-title":"Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: an NCDR Research to Practice (R2P) project","volume":"195","author":"Hess","year":"2018","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbrc.2020.04.157_bib11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2020.04.157_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.04.157_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ng.3300","article-title":"The impact of low-frequency and rare variants on lipid levels","volume":"47","author":"Surakka","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2020.04.157_bib14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2020.04.157_bib15","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1021\/bi060799c","article-title":"The gamma-secretase complex: membrane-embedded proteolytic ensemble","volume":"45","author":"Wolfe","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2020.04.157_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10637-014-0083-8","article-title":"A\u00a0phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma","volume":"32","author":"De Jesus-Acosta","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.bbrc.2020.04.157_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nm.2378","article-title":"Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner","volume":"17","author":"Pajvani","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.04.157_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.molmet.2015.11.006","article-title":"Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity","volume":"5","author":"Sparling","year":"2016","journal-title":"Mol. Metab."},{"issue":"468","key":"10.1016\/j.bbrc.2020.04.157_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2020.04.157_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","article-title":"Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation","volume":"82","author":"Milano","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbrc.2020.04.157_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature03659","article-title":"Notch\/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells","volume":"435","author":"van Es","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.04.157_bib22","doi-asserted-by":"crossref","first-page":"12876","DOI":"10.1074\/jbc.M311652200","article-title":"Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation","volume":"279","author":"Wong","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.04.157_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cmet.2018.02.010","article-title":"Gamma-secretase inhibition lowers plasma triglyceride-rich lipoproteins by stabilizing the LDL receptor","volume":"27","author":"Kim","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican1184-58","article-title":"How LDL receptors influence cholesterol and atherosclerosis","volume":"251","author":"Brown","year":"1984","journal-title":"Sci. Am."},{"key":"10.1016\/j.bbrc.2020.04.157_bib25","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2020.04.157_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCRESAHA.117.311361","article-title":"Novel reversible model of atherosclerosis and regression using oligonucleotide regulation of the LDL receptor","volume":"122","author":"Basu","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2020.04.157_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A\u00a0simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.04.157_bib28","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2017.08.039","article-title":"Degradation of PHLPP2 by KCTD17, via a glucagon-dependent pathway, promotes hepatic steatosis","volume":"153","author":"Kim","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2020.04.157_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF02536053","article-title":"Atherosclerosis and plasma and liver lipids in nine inbred strains of mice","volume":"28","author":"Nishina","year":"1993","journal-title":"Lipids"},{"key":"10.1016\/j.bbrc.2020.04.157_bib30","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1073\/pnas.97.7.3433","article-title":"Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: studies in C57BL\/6 apolipoprotein E knockout mice","volume":"97","author":"Sehayek","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2020.04.157_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.04.157_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.04.157_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/0976-9668.149117","article-title":"Association of atherosclerosis with dyslipidemia and co-morbid conditions: a descriptive study","volume":"6","author":"Garg","year":"2015","journal-title":"J.\u00a0Nat. Sci. Biol. Med."},{"key":"10.1016\/j.bbrc.2020.04.157_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","article-title":"Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies","volume":"259","author":"Thompson","year":"2006","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.bbrc.2020.04.157_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence","volume":"259","author":"Walldius","year":"2006","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.bbrc.2020.04.157_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-2011-101065","article-title":"The many substrates of presenilin\/gamma-secretase","volume":"25","author":"Haapasalo","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2020.04.157_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.04.157_bib38","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1371\/journal.pbio.0060257","article-title":"Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements","volume":"6","author":"Hemming","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2020.04.157_bib39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3233\/JAD-150982","article-title":"Inhibition of cholesterol biosynthesis reduces gamma-secretase activity and amyloid-beta generation","volume":"51","author":"Kim","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2020.04.157_bib40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1242\/bio.019802","article-title":"A\u00a0lipidomics study reveals hepatic lipid signatures associating with deficiency of the LDL receptor in a rat model","volume":"5","author":"Wang","year":"2016","journal-title":"Biol. Open"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20309025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20309025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:50:32Z","timestamp":1757764232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20309025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0006291X20309025"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.04.157","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-selective \u03b3-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.04.157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}